Fennec Pharma - Rasio nilai perusahaan marang dodolan FENC

Simbol resmi perusahaan fennecpharma.com (FENC)

The EV/Revenue trend confirms stable demand within the niche pediatric hearing protection segment, where clinic loyalty prevents sales declines for Fennec Pharmaceuticals (FENC). The current metric value of 6421.27 is driven by the commercialization of Pedmark as the primary profit generator. Revenues are based on the supply of this patented agent to specialized oncology centers, ensuring a sustainable cash flow.

Fennec (FENC): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Fennec Pharmaceuticals Inc - rincian analitis lan metrik utama (FENC)

Pambiji fundamental perusahaan:FENC, fennecpharma.com
Produk sing diprodhuksi Fennec Pharma

This ratio determines the market value of the entire business, adjusted for net debt, per unit of revenue. The algorithm eliminates the impact of leverage, allowing for an objective assessment of sales generation efficiency. By analyzing the EV/Sales ratio on the GURU.Markets platform, an investor identifies whether an asset is overbought or undervalued. For Fennec Pharmaceuticals (FENC), this indicator reflects market expectations regarding the transition to digital automation of clinical data. The metric shows how much the market is willing to pay for the future scalability of the company's software solutions.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Heron Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CRBP (Corbus Pharma)|CRDF: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan beyondspringpharma.com (BYSI)|Rasio nilai perusahaan marang pendapatan bioatla.com|LIXT: Nilai bisnis marang pendapatan|Multiplikator EV/Sales CTXR|Multiplikator EV/Sales Cellectar Corp (CLRB)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales